Disease specific quality of life instruments in multiple sclerosis: Validation of the Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS)

Abstract

Quality of life (QoL) is discussed as an additional outcome measure in multiple sclerosis (MS). However, few questionnaires assessing disease specific QoL in MS have been published. On the basis of the literature and interviews with clinicians and MS patients, we have developed a disease specific QoL instrument and validated it in a broad range of patients with MS. In this study, a heterogeneous sample of n=237 MS patients completed the newly developed Hamburg Quality of Life Questionnaire in Multiple Sclerosis (HAQUAMS, in German language) and a battery of already validated questionnaires. They further underwent neurological scoring and objective tests. By these means, we investigated its validity, appropriateness, internal consistency, and retest reliability. Internal consistency and retest coefficients were high and satisfied psychometric standards. Convergent and discriminant validity was supported by direction, magnitude and pattern of correlations with other health measures. HAQUAMS subscales and its total score distinguished between patient groups of varied disease severity, cognitive impairment, and affective symptomatology. No floor or ceiling effects were found in either of the HAQUAMS subscales. The HAQUAMS is a reliable, valid and appropriate instrument for QoL assessment in multiple sclerosis. Data of responsiveness are currently being obtained.

Keywords

multiple sclerosis quality of life questionnaire outcome measures disability ratings

Get full access to this article

View all access options for this article.

References

Sharrack B , Hughes RAC , Soudain S , Dunn G. (1999) The psychometric properties of clinical rating scales used in multiple sclerosis . Brain 122: 141-145 .

Hobart J , Freeman J , Thompson A. (2000) Kurtzke scales revisited: the application of psychometric methods to clinical intuition . Brain 123: 1027-1040 .

Rothwell PM , McDowell D , Wong CK , Dorman PJ. (1997) Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis . BMJ 314: 1580-1583 .

Cutter GR et al. (1999) Development of a multiple sclerosis functional composit as a clinical trial outcome measure . Brain 122: 871-882 .

Fischer JS et al. (1999) Recent developments in the assessment of quality of life in multiple sclerosis . Multiple Sclerosis 5: 251-259 .

Nordvedt MW , Riise T , Myhr KM , Nyland HI. (1999) Quality of life in multiple sclerosis. Measuring the disease effects more broadly . Neurology 53: 1098-1103 .

Schipper H , Clinch J , Olweny C. (1996) Quality of life studies: Definitions and conceptual issues. In: Spilker B (ed.). Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven Publishers: Philadelphia , pp 11-24.

Brown RS. (1999) Strategies and pitfalls in quality of life research . Hepatology 29: 9S-12S .

Freeman JA , Hobart JC , Langdon DW , Thompson AJ. (2000) Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis . J Neurol Neurosurg Psychiatry 68: 150-156 .

10.

Aaronson NK et al. (1993) The European organization for research and treatment of cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology . J Natl Cancer Inst 85: 365-376 .

11.

Drossman DA et al. (1989) Health related quality of life in inflammatory bowel disease: Functional status and patients worries and concerns . Dig Dis Sci 34: 1379-1386 .

12.

Younossi ZM , Kiwi M , King D , Guyatt G. (1997). A liver specific health related quality of life index: Chronic liver disease questionnaire . Hepatology 26: 355A-355A .

13.

Cella D et al. (1996) Validation of the functional assessment of multiple sclerosis quality of life instrument . Neurology 47: 129-139 .

14.

Vickrey BG et al. (1995) A health related quality of life measurement for multiple sclerosis . Qual Life Res 4: 187-206 .

15.

Ritvo PG et al. (1997) Multiple Sclerosis Quality of Life Inventory (MSQLI): a user's manual. National Multiple Sclerosis Society: New York .

16.

Pfennings LEMA et al. (1999) A health-related quality of life questionnaire for multiple sclerosis patients . Acta Neurol Scand 100: 148-155 .

17.

Ware JE , Kosinsky M , Keller SD. (1994) SF-36 physical and mental health summary scales. A user's manual. The Health Institute, New England Medical Center: Boston, MA .

18.

Bullinger M, Kirchberger I. (1998) [SF-36 health survey questionnaire]. Hogrefe: Göttingen.

19.

Heesen C et al. (1999) Multiple sclerosis impact on patient's life-a prospective correlation study of patient self estimation and standardized quantitative measurements . Multiple Sclerosis 5: S127-S127 .

20.

Gill TM , Feinstein AR. (1994) A critical appraisal of the quality of life measurements . JAMA 272: 619-626 .

21.

Poser CM , Paty DW , Scheinberg L. (1983) New diagnostic criteria for multiple sclerosis: Guidelines for research protocols . Ann Neurol 13: 227-231 .

22.

Kurtzke JM. (1983) Rating neurological impairment in multiple sclerosis: An expanded disability status scale . Neurology 33: 1444-1452 .

23.

Mumford C , Compston A. (1993) Problems with rating scales for multiple sclerosis: a novel approach-the CAMBS score . JNeurol 240: 209-215 .

24.

Zigmond AS , Snaith RP. (1983) the hospital anxiety and depression scale . Acta Psychiatr Scand 67: 361-370 .

25.

Herrmann C, Buss U, Snaith AP. (1995) [Hospital anxiety and depression scale-German version]. Huber: Bern.

26.

Smith A. (1968) The symbol digit modalities test . Learning Disorders 3: 83-91 .

27.

Deyo RA , Diehr P , Patrick DL. (1991) Reproducibility and responsiveness of health status measures-statistics and strategies for evaluation . Controlled Clinical Trials 12: 142S-158S .

28.

Kramer MS , Feinstein AR. (1981) Clinical biostatistics LIV. The biostatistics of concordance . Clinical Pharmacol Ther 29: 111-123 .

29.

Liang MH , Larson MG , Cullen KE , Schwartz JA. (1985) Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research . Arthritis Rheum 28: 542-547 .

30.

Ebers G. (1998) Natural history studies in multiple sclerosis. In: Compston A et al. (eds.) Multiple Sclerosis 3rd edn. Churchill Livingstone: London , pp 191-222.

31.

Krupp LB et al. (1995) Fatigue therapy in multiple sclerosis: results of a double blind randomized parallel trial of amantadine, pemoline, and placebo . Neurology 45: 1956-1961 .

32.

Khatri P et al. (1999) Perception of cognitive function in older adults following coronary artery bypass surgery . Health Psychol 18: 301-306 .

33.

Van der Putten JMF , Hobart JC , Freeman JA , Thompson AJ (1999) Measuring change in disability following inpatient rehabilitation: Comparison of the responsiveness of the Barthel index and the functional independence measure . J Neurol Neurosurg Psychiatry 66: 480-484 .

34.

Freeman JA , Langdon DW , Hobart JC , Thompson AJ. (1996) Health-related quality of life in people with multiple sclerosis undergoing inpatient rehabilitation . J Neuro Rehab 10: 185-194 .